IGG AND IGM ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH LUPUS WITH ANTICARDIOLIPIN ANTIBODY ASSOCIATED CLINICAL SYNDROMES
- 1 January 1988
- journal article
- research article
- Vol. 15 (5) , 795-798
Abstract
IgG and IgM anticardiolipin antibodies (aCL) were measured by a solid phase enzyme immunoassay in 64 patients with systemic lupus erythematosus who had one or more clinical disorders reported to be associated with aCL. We found the presence of IgG aCL was significantly associated with an increased incidence of cerebrovascular disease (p < 0.01), a positive Venereal Disease Research Laboratories (VDRL) test (p < 0.02) and prolonged partial thromboplastin time (PTT) (p < 0.001). IgM aCL were associated with recurrent spontaneous abortion (p < 0.05), thrombocytopenia (p < 0.05) as well as a positive VDRL and prolonged PTT. The combination of high titer IgG and IgM aCL was associated with endocardial disease (p = 0.02), migraine (p < 0.02), in addition to fetal loss (p < 0.001).This publication has 8 references indexed in Scilit:
- Anticardiolipin antibodies in patients with systemic lupus erythematosusArthritis & Rheumatism, 1987
- Anticardiolipin antibodies: isotype distribution and phospholipid specificity.Annals of the Rheumatic Diseases, 1987
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodyBritish Journal of Haematology, 1985
- ANTI-PHOSPHOLIPID ANTIBODIES IN SYPHILIS AND A THROMBOTIC SUBSET OF SLE - DISTINCT PROFILES OF EPITOPE SPECIFICITY1985
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS1963